Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease.
10.1016/j.apsb.2024.11.016
- Author:
Patil ASHWINI
1
;
Bodhankar SUBHASH
2
;
Muthal AMOL
2
;
Dileep KUMAR
1
;
Pawar ATMARAM
3
;
Kulkarni RAVINDRA
1
Author Information
1. Department of Pharmaceutical Chemistry, BVDU'S Poona College of Pharmacy, Erandwane Pune-411038, Maharashtra, India.
2. Department of Pharmacology, BVDU'S Poona College of Pharmacy, Erandwane Pune-411038, Maharashtra, India.
3. Department of Pharmaceutics, BVDU'S Poona College of Pharmacy, Erandwane Pune-411038, Maharashtra, India.
- Publication Type:Review
- Keywords:
Alzheimer's disease;
Amyloid hypothesis;
BIN1;
Kinase;
Notum inhibitors;
Tau targeting therapy;
Trem2
- From:
Acta Pharmaceutica Sinica B
2025;15(3):1281-1310
- CountryChina
- Language:English
-
Abstract:
Alzheimer's disease, a significant contributor to dementia, is rapidly becoming a serious healthcare concern in the 21st century. The alarming number of patients with Alzheimer's disease is steadily increasing, which is contributed by the dearth of treatment options. The current treatment for Alzheimer's disease is heavily dependent on symptomatic treatment that has failed to cure the disease despite huge investments in the development of drugs. The clinical treatment of Alzheimer's disease with limited drugs is generally targeted towards the inhibition of N-methyl-d-aspartate receptor and acetylcholine esterase, which only elevate cognition levels for a limited period. Beyond the aforementioned molecular targets, β-amyloid was much explored with little success and thus created a feel and palpable growing emphasis on discovering new putative and novel targets for AD. This has inspired medicinal chemists to explore new targets, including microglia, triggering receptors expressed on myeloid cells 2 (Trem-2), and notum carboxylesterase, to discover new lead compounds. This review explores the functions, pathophysiological roles, and importance of all AD-related targets that address therapeutic and preventive approaches for the treatment and protection of Alzheimer's disease.
